{"entity":{"type":"insider","cik":"0001306376","url":"/insider/0001306376","json_url":"/insider/0001306376.json","name":"Prunty John D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2007-11-19","last":"2008-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Prunty John D","source":"filing","n_filings":3,"first_seen":"2007-11-19","last_seen":"2008-12-22"}],"transactions":[{"id":2378618,"accession":"0001142576-08-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-08-000020","line_url":"/filing/0001142576-08-000020#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001306376","owner_name":"Prunty John D","owner_display_name":"Prunty John D","owner_url":"/insider/0001306376","role":"Officer (CFO and VP, Finance)","role_mark":"O","role_mark_label":"Officer (CFO and VP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and VP, Finance","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1942.0,"shares_display":"1,942","price_per_share":6.1795,"price_display":"6.18","price_state":"stated","total_value":12000.589,"total_display":"12,000.59","total_whole":"12,001","shares_owned_after":4878.0,"shares_owned_after_display":"4,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-17","filed_date":"2008-12-22","scope":"insider"},{"id":2378615,"accession":"0001142576-08-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-08-000016","line_url":"/filing/0001142576-08-000016#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001306376","owner_name":"Prunty John D","owner_display_name":"Prunty John D","owner_url":"/insider/0001306376","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1936.0,"shares_display":"1,936","price_per_share":6.035,"price_display":"6.04","price_state":"stated","total_value":11683.76,"total_display":"11,683.76","total_whole":"11,684","shares_owned_after":2936.0,"shares_owned_after_display":"2,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-16","scope":"insider"},{"id":7332373,"accession":"0001142576-07-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001142576-07-000016","line_url":"/filing/0001142576-07-000016#line-1","is_derivative":false,"issuer_cik":"0001142576","issuer_name":"OPTIMER PHARMACEUTICALS INC","issuer_ticker":"OPTR","issuer_name_source":null,"issuer_url":"/issuer/0001142576","owner_cik":"0001306376","owner_name":"Prunty John D","owner_display_name":"Prunty John D","owner_url":"/insider/0001306376","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":5950.0,"total_display":"5,950.00","total_whole":"5,950","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001142576","name":"OPTIMER PHARMACEUTICALS INC","url":"/issuer/0001142576","role":"Officer (CFO and VP, Finance)","n_filings":3,"first_seen":"2007-11-19","last_seen":"2008-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001306376","retrieved_at":"2026-08-25T16:36:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}